Breath Diagnostics Inc. and Mayo Clinic Laboratories announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The two organizations will initially focus on a test that can detect lung cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
